Ticker > Company >

Shilpa Medicare share price

Shilpa Medicare Ltd.

NSE: SHILPAMED BSE: 530549 SECTOR: Pharmaceuticals & Drugs  70k   180   34

984.35
-1.80 (-0.18%)
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 995.95

Today's Low

₹ 925

52 Week High

₹ 995.95

52 Week Low

₹ 518.4

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

9626.05 Cr.

Enterprise Value

9765.47 Cr.

No. of Shares

9.78 Cr.

P/E

137.9

P/B

3.56

Face Value

₹ 1

Div. Yield

0.1 %

Book Value (TTM)

₹  276.16

CASH

3.13 Cr.

DEBT

142.55 Cr.

Promoter Holding

44.23 %

EPS (TTM)

₹  7.14

Sales Growth

25.06%

ROE

1.26 %

ROCE

2.36%

Profit Growth

154.44 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year25.06%
3 Year6.42%
5 Year-14.14%

Profit Growth

1 Year-52.9%
3 Year-47.33%
5 Year-26.33%

ROE%

1 Year1.26%
3 Year0%
5 Year3.3%

ROCE %

1 Year2.36%
3 Year0.79%
5 Year4.03%

Debt/Equity

0.0665

Price to Cash Flow

1198.21

Interest Cover Ratio

3.2072

CFO/PAT (5 Yr. Avg.)

1.66048637379028

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 44.23 7.92
Dec 2024 44.23 7.92
Sep 2024 44.33 7.90
Jun 2024 44.39 90.41
Mar 2024 50.01 90.41
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 144.8696 Cr.
  • Company is virtually debt free.
  • Company’s PEG ratio is 0.892948896225078.
  • The company has an efficient Cash Conversion Cycle of 77.7921 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.66048637379028.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.96846968619313.

 Limitations

  • The company has shown a poor profit growth of -25.4800278584316% for the Past 3 years.
  • The company has shown a poor revenue growth of 6.41784374112666% for the Past 3 years.
  • Company has a poor ROE of -0.00419547935880008% over the past 3 years.
  • Company has a poor ROCE of 0.786698899258323% over the past 3 years
  • Company has contingent liabilities of 655.2432 Cr.
  • The company is trading at a high PE of 137.9.
  • The company is trading at a high EV/EBITDA of 46.7586.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 87.45 96.12 129.68 125.39 126.15
Total Expenditure 80.49 72.17 86.83 102.82 90.92
Operating Profit 6.96 23.95 42.86 22.56 35.23
Other Income 23.25 31.45 21.47 16.83 14.08
Interest 2.71 1.95 1.19 1.38 2.09
Depreciation 12.29 12.3 12.02 12.2 12.34
Exceptional Items -3.78 -0.46 -0.47 -0.49 -44.32
Profit Before Tax 11.43 40.69 50.65 25.33 -9.43
Tax 1.69 12.34 20.16 9.21 -4.28
Profit After Tax 9.74 28.35 30.49 16.12 -5.15
Adjusted EPS (Rs) 1.12 2.9 3.12 1.65 -0.53

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 805.97 257.05 356.95 247.7 309.79
Total Expenditure 568.18 228.58 345.93 302.88 287.72
Operating Profit 237.79 28.47 11.02 -55.17 22.07
Other Income 18.37 37.14 51.52 79.82 93.34
Interest 4.33 6.07 9.05 20.83 17.26
Depreciation 34.96 22.28 34.82 46.55 49.61
Exceptional Items -4.54 52.95 8.81 -15.55 -10.45
Profit Before Tax 212.34 90.21 27.49 -58.28 38.09
Tax 44.15 25.12 7.33 -8.79 11.15
Net Profit 193.72 184.39 140.99 57.19 26.94
Adjusted EPS (Rs.) 20.63 7.98 2.32 -5.7 3.1

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 8.15 8.15 8.68 8.68 8.68
Total Reserves 1445.27 1629.68 2056.99 2108.9 2134.04
Borrowings 164.48 324.52 120.28 122.8 16.25
Other N/C liabilities 43.52 81.06 89.87 35.56 33.28
Current liabilities 359.86 473.98 161.65 242.71 226.34
Total Liabilities 2021.28 2517.39 2896.12 2518.66 2418.58
Assets
Net Block 517 640.9 565.78 608.93 586.33
Capital WIP 244.18 297.19 52.57 41.84 9.92
Intangible WIP 128.63 185.16 240.55 184.59 218.32
Investments 93.48 219.32 237.5 243.92 246.45
Loans & Advances 124.54 391.84 595.14 802.92 980.26
Other N/C Assets 5.76 3.1 895.15 0.2 0.38
Current Assets 907.69 779.9 309.44 636.25 376.93
Total Assets 2021.28 2517.39 2896.12 2518.66 2418.58
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 233.99 255.54 192.89 12.68 38.09
Adjustment -5.39 -25.46 32.64 -35.56 7.17
Changes in Assets & Liabilities -57.95 -117.1 -17.17 33.37 -30.28
Tax Paid -40.85 -43.34 -34.49 -8.41 -6.95
Operating Cash Flow 129.79 69.63 173.87 2.08 8.03
Investing Cash Flow -302.49 -238.13 -378.97 -94.83 155.82
Financing Cash Flow 170.1 255.58 97.23 87.68 -163.07
Net Cash Flow -2.59 87.08 -107.88 -5.07 0.78

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 50.01 44.39 44.33 44.23 44.23
brijgopal innani 1.35 1.20 1.20 1.20 1.20
deepak kumar innani 3.15 2.80 2.80 2.80 2.80
dharmavati bhutada 7.15 6.35 6.35 6.35 6.35
kamalkishore innani 0.19 0.17 0.17 0.17 0.17
kantadevi inani 2.93 2.60 2.60 2.60 2.60
keerti innani 0.18 0.16 0.16 0.16 0.16
keshav bhutada 2.30 2.05 2.05 2.05 2.05
madhav vishnukant bhutada... 2.30 2.05 2.05 2.05 2.05
manjulatha innani 0.18 0.16 0.16 0.16 0.16
namrata bhutada 0.03 0.02 0.02 0.02 0.02
natamal innani 1.30 1.16 1.16 1.16 1.16
om prakash inani 3.30 2.93 2.93 2.93 2.93
priya inani - - 0.18 0.08 0.08
ramakant innani 1.73 1.53 1.53 1.53 1.53
ravi kumar innani 4.62 4.10 4.10 4.10 4.10
sagar innani 1.15 1.02 1.02 1.02 1.02
shakuntalabai innani 1.30 1.15 1.15 1.15 1.15
suraj kumar inani - - 4.01 4.01 4.01
taradevi innani 1.44 1.28 1.28 1.28 1.28
triveni inani 0.34 0.30 0.30 0.30 0.30
vishnukant chaturbhuj bhu... 7.33 6.51 6.51 6.51 6.51
vishnukanta inani 1.40 1.24 1.24 1.24 1.24
vishnukanth c bhutada (hu... - 1.37 1.37 1.37 1.37
priya innani 0.21 0.18 - - -
suraj kumar innani 4.59 4.07 - - -
vishnukanth c bhutada 1.54 - - - -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 49.99 55.61 55.67 55.77 55.77
akash bhanshali 1.84 1.64 1.55 1.55 1.52
bandhan small cap fund - 1.59 - 1.92 1.45
cohesion mk best ideas su... 1.38 2.12 2.12 2.17 2.17
dovetail india fund class... 1.08 1.52 1.52 1.52 1.52
elm park fund limited 1.38 1.23 1.23 1.23 1.23
icici prudential elss tax... - - - 2.40 2.04
investor education and pr... 0.31 0.29 0.29 - 0.29
pivotal enterprises priva... 2.53 2.25 2.25 2.25 2.25
sapphire intrex limited 1.23 1.09 1.09 1.09 1.09
sbi life insurance co. lt... - 1.25 1.61 1.72 1.75
viral parikh - - - 1.02 1.02
investor education and pr... - - - 0.29 -
bandhan core equity fund - - 1.74 - -
icici prudential pharma h... 1.44 2.82 2.74 - -
viral amal parikh 1.15 1.02 1.02 - -
amal n parikh 1.03 - - - -

Annual Reports

Title Action
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY ACTION
Credit ICRA
Credit ICRA
Credit ICRA
Credit CRISIL
Credit ICRA
TYPE AGENCY ACTION
Research BP Wealth

Concalls & Presentations

TYPE QUARTER ACTION
Concall Q4FY24
Concall Q4FY23
Concall Q3FY24
Concall Q3FY24
Concall Q2FY24
TYPE QUARTER ACTION
Presentation Q4FY24
Presentation Q4FY23
Presentation Q4FY21
Presentation Q4FY21
Presentation Q4FY20
Presentation Q3FY24
Presentation Q3FY23
Presentation Q3FY22
Presentation Q2FY24
Presentation Q1FY21

Company News

Shilpa Medicare Stock Price Analysis and Quick Research Report. Is Shilpa Medicare an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Shilpa Medicare and its performance over the period of time. Shilpa Medicare stock price today is Rs 985.8.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Shilpa Medicare cash from the operating activity was Rs 8.0337 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Shilpa Medicare has a Debt to Equity ratio of 0.0665 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Shilpa Medicare , the EPS growth was 154.4372 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Shilpa Medicare has OPM of 7.12393628388058 % which is a bad sign for profitability.
     
  • ROE: Shilpa Medicare have a poor ROE of 1.2646 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Shilpa Medicare is Rs 985.8. One can use valuation calculators of ticker to know if Shilpa Medicare share price is undervalued or overvalued.
Last Updated on:
Brief about Shilpa Medicare
X